DUBLIN--(BUSINESS WIRE)--The "Global
Pancreatic Fistula Treatment Market Size, Market Share, Application
Analysis, Regional Outlook, Growth Trends, Key Players, Competitive
Strategies and Forecasts, 2018 To 2026" report has been added
to ResearchAndMarkets.com's offering.
The global pancreatic fistula treatment market was valued at US$ 1,708.6
Mn in 2017 expanding at a CAGR of 5.7% from 2018 to 2026.
In terms of treatment, the pancreatic fistula treatment is categorized
into drugs and surgical devices. The drugs segment is further classified
into octreotide and total parenteral nutrition (TPN). The surgical
devices segment is expected to dominate the market during the forecast
period owing to comparatively higher adoption of medical devices to
diagnose and treat pancreatic fistula.
Increasing launches of generic drugs & pipeline of octreotide drugs in
clinical trials are expected to support the market growth in the near
future. Total parenteral nutrition segment dominated the drugs market in
2017 attributed to augmented demand for parenteral nutrition products
including single dose amino acid solution, carbohydrates, parenteral
lipid emulsion, trace elements, vitamins, and minerals as it suppresses
production of pancreatic enzymes by restricting the oral intake of food
and maintains the nutrition of the patient.
In addition, the extensive use of sphincterotome, biliary & pancreatic
stents, guidewires, balloons, and cannulae while performing ERCP to
manage pancreatic fistula is supporting the dominance of the surgical
devices segment.
The prominent players actively engaged in the pancreatic fistula
treatment market are Cook Medical, Inc., CONMED Corporation, Fresenius
Kabi AG, B. Braun Melsungen Ag, Becton Dickinson & Company, Medtronic
plc, Novartis AG and Others.
Market Dynamics
Drivers
-
High Incidence of Post-operative Pancreatic Fistula
-
High Clinical and Economical Impact
Challenges
-
Limited Efficacy of Current Treatments
Opportunities
-
Aggressive Diagnosis and Minimally Invasive Procedures
Key Market Movements
-
Rising prevalence of pancreatic cancer and neuroendocrine tumors
worldwide
-
Growing cases of post-operative pancreatic fistula to drive the growth
of pancreatic fistula treatment market
-
Organized guidelines for the treatment of pancreatic fistula
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Pancreatic Fistula Treatment Products: Market Dynamics and
Outlook
Chapter 4 Global Pancreatic Fistula Treatment Market, by Treatment Type,
2016-2026 (US$ Mn)
Chapter 5 Global Pancreatic Fistula Treatment Market, by Geography,
2016-2026 (US$ Mn)
Chapter 6 Company Profiles
-
Cook Medical, Inc.
-
Endo-Flex GmbH
-
CONMED Corporation
-
Fresenius Kabi AG
-
B. Braun Melsungen AG
-
Becton, Dickinson and Company
-
Medtronic plc
-
Olympus Corporation
-
Novartis AG
-
Baxter International, Inc.
-
Ethicon USA, LLC
